Replies to post #378878 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Elite chose partners poorly. Lannett barely penetrated Adderall XR market. Markets are forward looking and there was very little forward PE applied because there is virtually no growth. Pipeline stalled and is now starting to move again. There is concern about what CEO can actually bring to the table after SequestOx failure. That has tarnished him, hands down. He needs to prove he is worthy of investment. He has helped the company achieve CFP, now let’s see some real growth. Low single digit growth y/y is nothing to celebrate.

[IB_]

Didn't NasRat lower the threshold from $0.10 to $0.03 to sell shares to LPC ????????????

I believe Elite was, or about to be, cash flow positive at that time ????? I don't think he ever sold any shares to LPC at or below $0.03 ????????????????

The market may wonder why he lowered it to $0.03, basically where Elite has traded for years now ................

Remember when NasRat asked for shareholder approval to raise the authorized shares so he could "convert his shares back to common." ???? How many shareholders that voted YES, had any idea that he would raise it hundreds of millions of shares MORE than he needed to convert ???????

In my opinion, NasRat is the reason the share price is $0.03 per share and going nowhere anytime soon ..........................

Hey Thanks A Lot King,

IB_